Wave Life Sciences (WVE) Operating Margin Growth (1y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 1,216,509.61 Bn | 1,216,509.61 Bn | - | - |
| 2 | Alterity Therapeutics | 764,224.41 Bn | 764,224.38 Bn | - | - |
| 3 | Legend Biotech | 2,716.00 Bn | 2,715.71 Bn | 242.10 Mn | 3,609.00 |
| 4 | Nanobiotix | 2,248.83 Bn | 2,248.77 Bn | - | - |
| 5 | Akari Therapeutics | 1,951.18 Bn | 1,951.17 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 113.69 Bn | 106.44 Bn | 2.59 Bn | 1,536.00 |
| 7 | Evaxion A | 64.16 Bn | 64.14 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 63.94 Bn | 55.18 Bn | 3.31 Bn | -170.00 |
| 9 | Alnylam Pharmaceuticals | 40.13 Bn | 37.12 Bn | 959.66 Mn | -3,724.00 |
| 10 | Wave Life Sciences | 1.32 Bn | 772.50 Mn | - | 46,099.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 46,099.00 |
| Jun 30, 2025 | -42,877.00 |
| Mar 31, 2025 | -26,799.00 |
| Jun 30, 2024 | -7,154.00 |
| Mar 31, 2024 | -4,059.00 |
| Dec 31, 2023 | 345,168.00 |
| Sep 30, 2023 | 1.37 Mn |
| Jun 30, 2023 | 1.11 Mn |
| Mar 31, 2023 | 194,256.00 |
| Dec 31, 2022 | -147,009.00 |
| Sep 30, 2022 | -1.36 Mn |
| Jun 30, 2022 | -980,901.00 |
| Dec 31, 2021 | -172,475.00 |
| Sep 30, 2021 | 97,665.00 |
| Jun 30, 2021 | -15,769.00 |
| Dec 31, 2020 | 220,106.00 |
| Sep 30, 2020 | 85,221.00 |
| Jun 30, 2020 | -67,902.00 |
| Mar 31, 2020 | 38,439.00 |
| Dec 31, 2019 | -117,019.00 |
| Sep 30, 2019 | -99,882.00 |
| Jun 30, 2019 | 15,158.00 |
| Mar 31, 2019 | 92,997.00 |
| Dec 31, 2018 | 148,569.00 |
| Sep 30, 2018 | 115,311.00 |
| Jun 30, 2018 | 149,953.00 |
| Mar 31, 2018 | 276,016.00 |
| Dec 31, 2017 | -10,043.00 |
| Sep 30, 2017 | 239,214.00 |
| Jun 30, 2017 | 54,175.00 |
| Jun 30, 2016 | 8,927.00 |